Megamika 500mg Injection
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Amikacin (500mg)
Overview Megamika 500mg Injection
Cefamika 500mg Injection, a broad-spectrum antibiotic, combats various bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. Prophylactically, it prevents infections in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administered intravenously (drip) or intramuscularly by a healthcare professional, self-injection is strictly prohibited. Consistent, evenly-spaced dosing, as directed, is crucial; premature cessation risks relapse or infection exacerbation. Typical side effects involve injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitate medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is paramount, including potential monitoring via kidney function, hearing, and urinalysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Megamika 500mg Injection
Infections caused by bacteria
Major Benefits of Megamika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megamika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Megamika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megamika 500mg Injection works:
Bactrim 500mg Injection, an antibacterial agent, inhibits bacterial proliferation by disrupting the synthesis of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Megamika 500mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Megamika 500mg Injection during pregnancy poses a confirmed risk to fetal development, precluding its routine use. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justified if the potential advantages outweigh the inherent dangers. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Megamika 500mg is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Megamika 500mg Injection may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from operating a vehicle if these effects manifest.
KidneyCAUTION
Administering Megamika 500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Megamika 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Megamika 500mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates that dosage modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Megamika 500mg Injection :
Omit a Megamika 500mg Injection dose? Seek your physician's advice.
Facts to Know About Megamika 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently